Estimation of the Burden of Major Cancers in Korea

Yoon, Seok Jun; Lee, Heeyoung; Shin, Yang Sik; Kim, Yong Ik; Kim, Choon Yul; Chang, Hae Choon

doi:10.3346/jkms.2002.17.5.604

Cited by 22 publications

(34 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The first national BoD study in Korea using the DALY metric was presented in 2002 (12), and many diverse BoD studies have been conducted since (1314151617181920212223242526272829303132333435). The DALY concept, however, is primarily used academically and has not yet been actually utilized in the health policy arena.…”

Section: Introductionmentioning

confidence: 99%

Quantifying Burden of Disease to Measure Population Health in Korea

Yoon

2016

J Korean Med Sci

View full text Add to dashboard Cite

Quantitative assessments of the health status of a population are essential to make decisions and set priorities in the field of public health. Changing epidemiologic patterns increase the demand for comprehensive estimates of population health across the full health spectrum, including non-communicable diseases and injuries. Burden of disease (BoD) analysis has helped meet this need. With the success of the Global Burden of Disease (GBD) Study, the BoD technique has become predominantly associated with the GBD approach and its methodology using disability-adjusted life year (DALY) has been rapidly disseminated and generally accepted over the last several years. The first Korean BoD study using the DALY metric was presented in 2002. Various BoD studies have since been conducted, but the DALY concept has remained primarily academic and has not yet been actively utilized in the health policy arena. Here, we review the DALY metric and population-based Korean BoD studies using national health data, with the intent of increasing the understanding of their value and their potential role in strengthening future assessments of the Korean population’s health status.

show abstract

Section: Introductionmentioning

confidence: 99%

Quantifying Burden of Disease to Measure Population Health in Korea

Yoon

2016

J Korean Med Sci

View full text Add to dashboard Cite

show abstract

“…The methods used in this analysis have been extensively described and documented in the peer-reviewed literature on the measurement of the burden of disease [6][7][8][9][10][11][12][13][14][15] . Mortality data for the USA for the year 2001 were obtained from the National Center for Health Statistics website (http://www.cdc.gov/nchs).…”

Section: Methodsmentioning

confidence: 99%

Average Years of Potential Life Lost in Those Who Have Died from Brain and CNS Tumors in the USA

Thuppal

Propp²,

McCarthy³

2006

Neuroepidemiology

View full text Add to dashboard Cite

The aim of this study was to quantify the impact of all primary malignant and nonmalignant brain and central nervous system (CNS) tumors on mortality in the USA in terms of years of life lost, an indicator of premature mortality in the population. In this study, US mortality data for the year 2001 from the National Center for Health Statistics and life tables from the US Census Bureau were used. Person-years of potential life lost (PYPLL) and average years of potential life lost (AYPLL) were calculated for all deaths due to brain and CNS tumors as an underlying cause. 16,819 deaths due to brain and CNS tumors occurred in 2001, leading to a total loss of 357,483 person-years of life and an average loss of 21.3 years (AYPLL). Hispanic men and women had an AYPLL of 31.7 and 33.9 years, respectively, a figure substantially higher than other race and ethnicity categories. Malignant tumors led to an AYPLL of 25 years, which was significantly higher than the AYPLL of 19 years due to nonmalignant tumors. The relative impact of tumors arising in the various anatomical sites in the brain and CNS among adults and among children was not similar. The use of population survival indicators, such as PYPLL and AYPLL, will help better understanding of the effect of racial, ethnic, gender and age differences on the mortality due to malignant and nonmalignant brain and CNS tumors. Information on years of life lost, as well as mortality data, will be useful in focusing research priorities and resources in this field.

show abstract

“…It has been considered to be less common among Asians and Caucasians [6,7] . However, recent studies have shown an increasing trend in these populations [8][9][10] . Variation in the incidence of colorectal neoplasia has been observed in populations and even in cities of one country.…”

Section: Introductionmentioning

confidence: 99%